Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in Advanced Liposarcoma
NCT01506596Phase 2Completed
- Sponsor
- Vector Oncology
- Start
- Mar 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in Liposarcoma, sponsored by Vector Oncology. Started Mar 2012; status: completed.
02
Drugs
pazopanib
03
Conditions
Liposarcoma
Beyond the preview
Go deeper on NCT01506596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01506596.